$ORGN
Origin Materials, Inc. Stock $orgn

$orgn Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000180245722000007 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue			$2.880M
YoY Change
Gross Profit			-$2.880M
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.055M	$17.27M	$4.520M
YoY Change	-10.29%	163.07%
% of Gross Profit
Research & Development	$3.519M	$9.124M	$830.0K
YoY Change	323.98%	120.49%
% of Gross Profit
Depreciation & Amortization	$182.0K	$544.0K	$170.0K
YoY Change	7.06%	13.57%
% of Gross Profit
Operating Expenses	$7.755M	$26.93M	$0.00
YoY Change		140.9%
Operating Profit			-$2.880M
YoY Change
Interest Expense	$1.514M	$2.838M	-$22.92M
YoY Change	-106.61%	732.26%
% of Operating Profit
Other Income/Expense, Net	$11.48M	$69.02M	-$16.80M
YoY Change	-168.32%	-460.96%
Pretax Income	$5.237M	$42.09M	-$25.80M
YoY Change	-120.3%	-238.9%
Income Tax		$3.000K
% Of Pretax Income		0.01%
Net Earnings	$5.237M	$42.09M	-$25.80M
YoY Change	-120.3%	-238.9%
Net Earnings / Revenue
Basic Earnings Per Share		$0.42
Diluted Earnings Per Share	$37.06K	$0.40	-$284.9K
COMMON SHARES
Basic Shares Outstanding	141.3M shares	101.2M shares
Diluted Shares Outstanding		106.2M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$444.1M	$444.1M	$1.309M
YoY Change	33826.28%	33826.28%
Cash & Equivalents	$46.64M		$1.309M
Short-Term Investments	$397.5M	$397.5M	$0.00
Other Short-Term Assets	$4.466M	$4.466M	$220.9K
YoY Change	1922.0%	589.2%
Inventory
Prepaid Expenses			$220.9K
Receivables
Other Receivables	$2.612M		$48.00K
Total Short-Term Assets	$451.2M	$451.2M	$2.005M
YoY Change	22402.39%	22402.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.19M	$58.97M	$45.10M
YoY Change	26.78%	30.74%
Goodwill
YoY Change
Intangibles	$215.0K		$258.0K
YoY Change	-16.67%
Long-Term Investments			$724.7M
YoY Change
Other Assets	$62.00K	$62.00K	$62.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$59.24M	$59.24M	$45.42M
YoY Change	30.42%	30.42%
TOTAL ASSETS
Total Short-Term Assets	$451.2M	$451.2M	$2.005M
Total Long-Term Assets	$59.24M	$59.24M	$45.42M
Total Assets	$510.4M	$510.4M	$47.43M
YoY Change	976.17%	976.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.451M	$2.451M	$2.700M
YoY Change	-9.22%	-9.22%
Accrued Expenses	$973.0K	$1.253M	$593.0K
YoY Change	64.08%	111.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.187M	$4.187M	$7.764M
YoY Change	-46.07%	-46.07%
LONG-TERM LIABILITIES
Long-Term Debt	$5.189M	$5.189M	$0.00
YoY Change		-14.86%
Other Long-Term Liabilities	$2.946M	$197.5M	$2.500M
YoY Change	17.84%	490.58%
Total Long-Term Liabilities	$2.946M	$202.7M	$2.500M
YoY Change	17.84%	412.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.187M	$4.187M	$7.764M
Total Long-Term Liabilities	$2.946M	$202.7M	$2.500M
Total Liabilities	$206.9M	$206.9M	$47.31M
YoY Change	337.38%	337.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$56.80M		-$98.89M
YoY Change	-42.56%
Common Stock	$16.00K		$6.000K
YoY Change	166.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$303.5M	$303.5M	$122.0K
YoY Change
Total Liabilities & Shareholders Equity	$510.4M	$510.4M	$47.43M
YoY Change	976.17%	976.17%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$5.237M	$42.09M	-$25.80M
YoY Change	-120.3%	-238.9%
Depreciation, Depletion And Amortization	$182.0K	$544.0K	$170.0K
YoY Change	7.06%	13.57%
Cash From Operating Activities	-$6.427M	-$22.04M	-$138.3K
YoY Change	4548.15%	303.64%
INVESTING ACTIVITIES
Capital Expenditures	-$7.356M	$12.27M	$650.0K
YoY Change	-1231.69%	586.9%
Acquisitions
YoY Change
Other Investing Activities	-$399.2M	-$399.2M	$0.00
YoY Change
Cash From Investing Activities	-$406.5M	-$411.6M	$0.00
YoY Change		19940.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$74.00K
YoY Change		7300.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	274.0K	$478.9M	0.000
YoY Change		8116.64%
NET CHANGE
Cash From Operating Activities	-6.427M	-$22.04M	-138.3K
Cash From Investing Activities	-406.5M	-$411.6M	0.000
Cash From Financing Activities	274.0K	$478.9M	0.000
Net Change In Cash	-412.7M	$45.25M	-138.3K
YoY Change	298358.09%	-2703.74%
FREE CASH FLOW
Cash From Operating Activities	-$6.427M	-$22.04M	-$138.3K
Capital Expenditures	-$7.356M	$12.27M	$650.0K
Free Cash Flow	$929.0K	-$34.31M	-$788.3K
YoY Change	-217.85%	373.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001802457
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-04321
CY2021	dei	Entity Registrant Name EntityRegistrantName	ORIGIN MATERIALS, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1388928
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	930 Riverside Parkway
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 10
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	West Sacramento,
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95605
CY2021	dei	City Area Code CityAreaCode	916
CY2021	dei	Local Phone Number LocalPhoneNumber	231-9329
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	899500000	USD
CY2021	dei	Entity Bankruptcy Proceedings Reporting Current EntityBankruptcyProceedingsReportingCurrent	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	141301569	shares
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021	dei	Auditor Location AuditorLocation	San Jose, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46637000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1309000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	565000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	397458000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2612000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	48000	USD
CY2021Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	202000	USD
CY2020Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3774000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	83000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	451173000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2005000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57185000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45104000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1782000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	258000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62000	USD
CY2021Q4	us-gaap	Assets Assets	510417000	USD
CY2020Q4	us-gaap	Assets Assets	47429000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2451000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2700000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	973000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	593000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1239000	USD
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3232000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	280000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	380000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	USD
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	103000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4187000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7764000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	906000	USD
CY2021Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	127757000	USD
CY2020Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	0	USD
CY2021Q4	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	6762000	USD
CY2020Q4	orgn	Research And Development Program Liability Noncurrent ResearchAndDevelopmentProgramLiabilityNoncurrent	6197000	USD
CY2021Q4	orgn	Redeemable Convertible Preferred Stock Warrants Noncurrent RedeemableConvertiblePreferredStockWarrantsNoncurrent	0	USD
CY2020Q4	orgn	Redeemable Convertible Preferred Stock Warrants Noncurrent RedeemableConvertiblePreferredStockWarrantsNoncurrent	19233000	USD
CY2021Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	52860000	USD
CY2020Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	0	USD
CY2021Q4	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5189000	USD
CY2020Q4	orgn	Stockholder Note Liabilities Noncurrent StockholderNoteLiabilitiesNoncurrent	5189000	USD
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5720000	USD
CY2020Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5517000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1486000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2946000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2500000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	206907000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	47306000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141301569	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141301569	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70266925	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70266925	shares
CY2021Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2021Q4	orgn	Sponsor Vesting Shares Issued SponsorVestingSharesIssued	4500000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	361542000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	98620000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56797000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98887000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1251000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	384000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	303510000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	510417000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47429000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9124000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4138000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17265000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6563000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	544000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	479000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	26933000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	11180000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	1413000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2021	us-gaap	Interest Expense InterestExpense	2838000	USD
CY2020	us-gaap	Interest Expense InterestExpense	341000	USD
CY2021	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1326000	USD
CY2020	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1088000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	385405000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-395000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1203000	USD
CY2021	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	4525000	USD
CY2020	orgn	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	18498000	USD
CY2021	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	75488000	USD
CY2020	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	USD
CY2021	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	811000	USD
CY2020	us-gaap	Other Nonrecurring Gain OtherNonrecurringGain	805000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	69023000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19122000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1712000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	77000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	794000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40455000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29508000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2021	orgn	Equity Issuance Costs EquityIssuanceCosts	37000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101221781	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544933	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106237754	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544933	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27999000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1630000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	794000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123000	USD
CY2021	orgn	Reclassification Of Stockholders Convertible Notes Payable ReclassificationOfStockholdersConvertibleNotesPayable	20491000	USD
CY2021	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability	54274000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1635000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	303510000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30302000	USD
CY2021	orgn	Reclassification Of Equity To Liability Related To Earn Out Provisions Of Business Combination ReclassificationOfEquityToLiabilityRelatedToEarnOutProvisionsOfBusinessCombination	-203082000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	77000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5767000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	42090000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	544000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	479000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	280000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5767000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1630000	USD
CY2021	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	14000	USD
CY2020	orgn	Amortization Of Deb Issuance Costs AmortizationOfDebIssuanceCosts	90000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	380000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	USD
CY2021	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	2211000	USD
CY2020	orgn	Accretion Of Debt Discount AccretionOfDebtDiscount	101000	USD
CY2021	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1326000	USD
CY2020	orgn	Change In Fair Value Of Derivatives ChangeInFairValueOfDerivatives	1088000	USD
CY2021	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	4525000	USD
CY2020	orgn	Change In Fair Value Of Warrants Liability ChangeInFairValueOfWarrantsLiability	18498000	USD
CY2021	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	75488000	USD
CY2020	orgn	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	0	USD
CY2021	orgn	Operating Lease Principal Payments OperatingLeasePrincipalPayments	295000	USD
CY2020	orgn	Operating Lease Principal Payments OperatingLeasePrincipalPayments	0	USD
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2563000	USD
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1007000	USD
CY2021	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	0	USD
CY2020	orgn	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	-87000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3652000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-53000	USD
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	203000	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	256000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3010000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	349000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22043000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5461000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12268000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1786000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2448316000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2024089000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25058000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
CY2021	orgn	Payments Of Interest Capitalized To Property Plant And Equipment PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment	201000	USD
CY2020	orgn	Payments Of Interest Capitalized To Property Plant And Equipment PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment	268000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45253000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1738000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-411638000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2054000	USD
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	11707000	USD
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	3166000	USD
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	906000	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2021	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	543000	USD
CY2020	orgn	Proceeds From Research And Development Program ProceedsFromResearchAndDevelopmentProgram	2662000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	74000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000	USD
CY2021	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	USD
CY2020	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	478948000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5829000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-52000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3612000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47127000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	USD
CY2021	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	20493000	USD
CY2020	orgn	Conversion Of Stockholder Convertible Notes Payable To Common Stock ConversionOfStockholderConvertibleNotesPayableToCommonStock	0	USD
CY2021	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	54267000	USD
CY2020	orgn	Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock	0	USD
CY2021	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	203082000	USD
CY2020	orgn	Reclassification Of Contingently Issued Equity To Liability ReclassificationOfContingentlyIssuedEquityToLiability	0	USD
CY2021	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	81364000	USD
CY2020	orgn	Net Assets Assumed From Business Combination NetAssetsAssumedFromBusinessCombination	0	USD
CY2021	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	2196000	USD
CY2020	orgn	Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities	0	USD
CY2021	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	609000	USD
CY2020	orgn	Business Combination Transaction Costs Accrued But Not Paid BusinessCombinationTransactionCostsAccruedButNotPaid	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2062000	USD
CY2021	orgn	Proceeds For Business Combination ProceedsForBusinessCombination	444600000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock and valuation of convertible preferred stock warrants prior to the Business Combination, valuation of the earnout liability, valuation of assumed common stock warrants liability, carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, marketable securities, stock-based compensation expense, probabilities of achievement of performance conditions on performance stock awards, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47127000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and marketable securities accounts with a financial institution where, at times, deposits exceed federal insurance limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on these deposits.
CY2019Q4	orgn	Escrow Deposit Fair Value EscrowDepositFairValue	1300000	USD
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	300000	USD
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	300000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46637000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1309000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	490000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	565000	USD
CY2021	orgn	Grants Received GrantsReceived	0	USD
CY2020	orgn	Grants Received GrantsReceived	200000	USD
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	orgn	Percent Of Occurrence Of A Tender Offer Or Exchange Of Our Stockholders PercentOfOccurrenceOfATenderOfferOrExchangeOfOurStockholders	0.50
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2021	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	2200000	USD
CY2020	orgn	Accretion Expense For Debt Issuance Cost AccretionExpenseForDebtIssuanceCost	100000	USD
CY2021	orgn	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	3	plan
CY2021Q2	orgn	Business Combination Reversion Recapitalization Conversion Ratio BusinessCombinationReversionRecapitalizationConversionRatio	2.11
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	200000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36700000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	295000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2007000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	397458000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	346300000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2021Q2	orgn	Proceeds For Business Combination Net Of Issuance Costs Paid ProceedsForBusinessCombinationNetOfIssuanceCostsPaid	467530000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1800000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1800000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	399170000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2024100000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	97438000	USD
CY2021Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo	146197000	USD
CY2021Q4	orgn	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Two Years DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterTwoYears	153802000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	397458000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64725000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	52146000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7540000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7042000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57185000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45104000	USD
CY2020	us-gaap	Depreciation Depreciation	500000	USD
CY2021	us-gaap	Depreciation Depreciation	500000	USD
CY2021Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	900000	USD
CY2020Q4	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	700000	USD
CY2021Q4	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	-100000	USD
CY2020Q4	orgn	Cumulative Translation Adjustment CumulativeTranslationAdjustment	900000	USD
CY2016Q4	orgn	Proceeds From Collaborative Agreement ProceedsFromCollaborativeAgreement	500000	USD
CY2021	us-gaap	Other Income OtherIncome	500000	USD
CY2020	us-gaap	Other Income OtherIncome	600000	USD
CY2016Q4	orgn	Proceeds From Collaborative Agreement ProceedsFromCollaborativeAgreement	500000	USD
CY2018Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	1500000	USD
CY2021	orgn	Number Of Offtake Supply Agreements NumberOfOfftakeSupplyAgreements	4	agreement
CY2021	orgn	Number Of Terminable Offtake Supply Agreements NumberOfTerminableOfftakeSupplyAgreements	2	agreement
CY2021Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	10900000	USD
CY2020Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	10700000	USD
CY2020	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	900000	USD
CY2021	orgn	Offtake Agreement Exercise Period OfftakeAgreementExercisePeriod	P1Y
CY2021	orgn	Offtake Agreement Purchase Period OfftakeAgreementPurchasePeriod	P10Y
CY2016Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	5000000	USD
CY2021	orgn	Earnout Shares Post Triggering Event Period EarnoutSharesPostTriggeringEventPeriod	P10D
CY2021Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares
CY2019Q2	orgn	Lesser Eligible Costs Percentage LesserEligibleCostsPercentage	0.1848
CY2019Q2	orgn	Lesser Eligible Costs LesserEligibleCosts	23000000	CAD
CY2019Q2	orgn	Funding Repayment Period FundingRepaymentPeriod	P15Y
CY2019Q2	orgn	Development Program Liability Maximum Repayment Ratio Compared To Actual Funding Received DevelopmentProgramLiabilityMaximumRepaymentRatioComparedToActualFundingReceived	1.25
CY2021Q2	orgn	Development Program Liability Funding Reduction Percentage DevelopmentProgramLiabilityFundingReductionPercentage	0.50
CY2019Q2	orgn	Minimum Costs Of Commercial Plants MinimumCostsOfCommercialPlants	500000000	CAD
CY2019Q2	orgn	Commercial Plants Constructed And Operational Period CommercialPlantsConstructedAndOperationalPeriod	P30M
CY2021Q4	orgn	Funding Liability FundingLiability	6800000	USD
CY2020Q4	orgn	Funding Liability FundingLiability	6200000	USD
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35476667	shares
CY2021Q4	orgn	Assumed Common Stock Warrants Liability Noncurrent AssumedCommonStockWarrantsLiabilityNoncurrent	52900000	USD
CY2021	orgn	Change In Fair Value Of Gain Loss Assumed Warrants ChangeInFairValueOfGainLossAssumedWarrants	30500000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2021Q4	orgn	Sponsor Vesting Shares Outstanding SponsorVestingSharesOutstanding	4500000	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18467109	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P4Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7667247	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10244399	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4130184	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2150941	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	49260254	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6600000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7300000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	43645000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-29162000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1554000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1141000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42091000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30303000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24899000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	390000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	0	USD
CY2021Q4	orgn	Deferred Tax Assets Leasing Arrangments DeferredTaxAssetsLeasingArrangments	341000	USD
CY2020Q4	orgn	Deferred Tax Assets Leasing Arrangments DeferredTaxAssetsLeasingArrangments	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	230000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	149000	USD
CY2021Q4	orgn	Deferred Tax Assets Property Plant And Equipment And Intangibles DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles	89000	USD
CY2020Q4	orgn	Deferred Tax Assets Property Plant And Equipment And Intangibles DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles	114000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25949000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18663000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	344000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	344000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25605000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18663000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6900000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1900000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	97800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	36800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	6700000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.013
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.001
CY2021	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent	-0.333
CY2020	orgn	Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent	-0.131
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.156
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.064
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.016
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	324000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	42090000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30302000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	68000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.015
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	orgn	Lessee Operating Lease Number Of Amended Leases LesseeOperatingLeaseNumberOfAmendedLeases	2	lease
CY2021	us-gaap	Lease Cost LeaseCost	392000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1782000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y5M8D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.028
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	271000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2062000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	327000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	300000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	269000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	257000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	264000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	528000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1945000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	179000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	280000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1486000	USD
CY2021	orgn	Royalty Payment For License Agreement RoyaltyPaymentForLicenseAgreement	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	42090000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-30302000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101221781	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62544933	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106237754	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62544933	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2021	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	2342466	shares
CY2020	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2021Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	1481531	shares
CY2021Q4	orgn	Common Stock Performance Shares CommonStockPerformanceShares	2137500	shares
CY2021Q4	orgn	Common Stock Earnout Shares CommonStockEarnoutShares	25000000	shares
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	4500000	shares

Files In Submission

Name	View Source	Status
0001802457-22-000007-index-headers.html	Edgar Link	pending
0001802457-22-000007-index.html	Edgar Link	pending
0001802457-22-000007.txt	Edgar Link	pending
0001802457-22-000007-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgn-20211231.htm	Edgar Link	pending
orgn-20211231.xsd	Edgar Link	pending
orgn-20211231xexx231.htm	Edgar Link	pending
orgn-20211231xexx311.htm	Edgar Link	pending
orgn-20211231xexx312.htm	Edgar Link	pending
orgn-20211231xexx313.htm	Edgar Link	pending
orgn-20211231xexx321.htm	Edgar Link	pending
orgn-20211231xexx45.htm	Edgar Link	pending
orgn-20211231_cal.xml	Edgar Link	unprocessable
orgn-20211231_def.xml	Edgar Link	unprocessable
orgn-20211231_g1.jpg	Edgar Link	pending
orgn-20211231_g2.jpg	Edgar Link	pending
orgn-20211231_g3.jpg	Edgar Link	pending
orgn-20211231_htm.xml	Edgar Link	completed
orgn-20211231_lab.xml	Edgar Link	unprocessable
orgn-20211231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGN
Origin Materials, Inc. Stock $orgn

2021 Q4 Form 10-K Financial Statement

#000180245722000007 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN Origin Materials, Inc. Stock $orgn

2021 Q4 Form 10-K Financial Statement

#000180245722000007 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGN
Origin Materials, Inc. Stock $orgn